| Lance D Breit, CRNA | |
|
2720 Stone Park Blvd, Sioux City, IA 51104-3734 | |
| (712) 255-2324 | |
| Not Available |
| Full Name | Lance D Breit |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 20 Years |
| Location | 2720 Stone Park Blvd, Sioux City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013954148 | NPI | - | NPPES |
| 047Z191 | Medicaid | IA | |
| 0123695 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 111812 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dunes Surgical Hospital | Dakota dunes, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Siouxland Anesthesiology Ltd | 2668453069 | 36 |
News Archive
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
Integrating a coach-led neuromuscular warm-up prior to sports practice appeared to reduce the risk of lower extremity injuries in female high school soccer and basketball athletes, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal Annals of Internal Medicine.
› Verified 3 days ago
| Entity Name | Siouxland Anesthesiology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669496337 PECOS PAC ID: 2668453069 Enrollment ID: O20040529000159 |
News Archive
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
Integrating a coach-led neuromuscular warm-up prior to sports practice appeared to reduce the risk of lower extremity injuries in female high school soccer and basketball athletes, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal Annals of Internal Medicine.
› Verified 3 days ago
| Entity Name | Rivers Edge Aesthetic Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1285936641 PECOS PAC ID: 3274707492 Enrollment ID: O20111202000773 |
News Archive
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
Integrating a coach-led neuromuscular warm-up prior to sports practice appeared to reduce the risk of lower extremity injuries in female high school soccer and basketball athletes, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal Annals of Internal Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lance D Breit, CRNA Po Box 683, Sioux City, IA 51102-0683 Ph: (712) 255-2324 | Lance D Breit, CRNA 2720 Stone Park Blvd, Sioux City, IA 51104-3734 Ph: (712) 255-2324 |
News Archive
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
Patients with multiple sclerosis who have breakthrough disease activity early in the course of treatment with interferon beta-1a are at high risk for severe worsening and poor long-term outcomes, research shows.
Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The CHMP did not support an indication for the treatment of schizophrenia.
Integrating a coach-led neuromuscular warm-up prior to sports practice appeared to reduce the risk of lower extremity injuries in female high school soccer and basketball athletes, according to a report in the November issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A new blood test could enable doctors to rule out tuberculosis (TB) infection within days rather than weeks, according to a new study published this week in the journal Annals of Internal Medicine.
› Verified 3 days ago
Robert Baczwaski, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-255-2324 | |
Raichatou Ann Jackson, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 | |
Patrick Menke, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 | |
Deborah Carter, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 801 5th St, Sioux City, IA 51101 Phone: 712-279-2505 | |
Dr. Jared Gregory Feiner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3500 | |
Mr. Robert A Schoenfelder, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2720 Stone Park Blvd, Sioux City, IA 51104 Phone: 712-279-3290 |